BioLineRx (BLRX) Change in Account Payables (2014 - 2024)
BioLineRx (BLRX) recorded quarterly Change in Account Payables of $711000.0 in Q4 2024, up 221.33% quarter-over-quarter from -$586000.0 in Q3 2024, and down 77.07% on a YoY basis from $3.1 million in Q1 2024.
BioLineRx (BLRX) Change in Account Payables (2014 - 2024) Analysis & Trends
BioLineRx's Change in Account Payables history runs 11 years deep, the most recent figure standing at $711000.0 for Q4 2024.
- In Q4 2024, Change in Account Payables fell 77.07% year-over-year to $711000.0; the TTM figure through Dec 2024 stood at -$5.5 million (down 199.93% YoY), while the FY2025 annual figure was -$3.5 million, up 36.86% from the prior year.
- Change in Account Payables was $711000.0 for Q4 2024 at BioLineRx, up from -$586000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $3.1 million in Q4 2023 to a low of -$3.5 million in Q1 2024.
- Historically, Change in Account Payables has averaged $81117.6 across 5 years, with a median of $180000.0 in 2021.
- The sharpest annual moves came in 2022 and 2024: Change in Account Payables surged 567.56% in 2022, then sank 1811.71% in 2024.
- A 5-year view of Change in Account Payables shows it stood at $51000.0 in 2020, then soared by 341.18% to $225000.0 in 2021, then soared by 567.56% to $1.5 million in 2022, then soared by 106.46% to $3.1 million in 2023, then tumbled by 77.07% to $711000.0 in 2024.
- The last three Change in Account Payables figures came in at $711000.0 (Q4 2024), -$586000.0 (Q3 2024), and -$2.1 million (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -9.42 Mn |
| 10 | BioLineRx | 227.63 Mn | 211.90 Mn | 154,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 711,000.00 |
| Dec 31, 2024 | 711,000.00 |
| Sep 30, 2024 | -586,000.00 |
| Sep 30, 2024 | -586,000.00 |
| Jun 30, 2024 | -2.12 Mn |
| Jun 30, 2024 | -2.12 Mn |
| Mar 31, 2024 | -3.51 Mn |
| Mar 31, 2024 | -3.51 Mn |
| Dec 31, 2023 | 3.10 Mn |
| Dec 31, 2023 | 3.10 Mn |
| Sep 30, 2023 | 2.13 Mn |
| Sep 30, 2023 | 2.13 Mn |
| Jun 30, 2023 | -111,000.00 |
| Jun 30, 2023 | -111,000.00 |
| Mar 31, 2023 | 394,000.00 |
| Mar 31, 2023 | 394,000.00 |
| Dec 31, 2022 | 1.50 Mn |
| Dec 31, 2022 | 1.50 Mn |
| Sep 30, 2022 | -1.29 Mn |
| Sep 30, 2022 | -1.29 Mn |